Status:
TERMINATED
Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
The Research Council of Norway
The Norwegian Women´s Public Health Association
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Palpable breast cancer lesion
Exclusion
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00184210
Start Date
January 1 2000
End Date
December 1 2020
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwegian University of Technology and Science
Trondheim, Norway, 7491